News

Edwards Lifesciences has announced that the Court of Appeals for the Federal Circuit affirmed a previous court decision in favor of Cook and WL Gore & Associates. The

Keryx Biopharmaceuticals has announced results of the Open Label Extension (OLE) trial of Zerenex for the treatment of elevated serum phosphorous levels, or hyperphosphatemia, in patients with end-stage

Gilead Sciences has revealed that the European Commission has granted conditional marketing authorisation for Cayston 75mg powder and solvent for nebuliser solution for the suppressive therapy of chronic

GATC Biotech has revealed that it is now offering human genome sequencing services using enrichment technologies from Agilent along with sequencing systems such as Roche GS FLX and

Bayer HealthCare and Onyx Pharmaceuticals have announced the full results from the randomised, double-blind, placebo controlled phase II trial showing that Nexavar (sorafenib tablets) in combination with the

Pharming Group has received confirmation of validation from EMEA of its Marketing Authorization Application (MAA) for Rhucin. Consequently the formal scientific evaluation procedure of the European Medicines Agency

InVitria has launched a new cell culture supplement for CHO (Chinese hamster ovaries) cell line enhancement called Zap-CHO at the 9th Protein Expression in Animal Cells (PEACe) Conference

Oxygen Biotherapeutics has received approval from Israel’s Ministry of Health to begin a phase II-b, dose escalation, clinical trial in the country for use of Oxycyte in traumatic

Gerresheimer, a pharmaceutical packaging manufacturer, has opened a R&D center in the US. It has also inaugurated a new factory in Spain for plastic drugs packaging. The company